A comparison of Twist and E-cadherin protein expression in primary non-small-cell lung carcinoma and corresponding metastases

European Journal of Cardio-thoracic Surgery

Volumn 39, Issue 6, 2011, Pages 1028-1032

  Wang, Guanghui ^a   Dong, Wei ^a   Shen, Hongchang ^a   Mu, Xueru ^a   Li, Zhenxiang ^a   Lin, Xiaoyan ^a   Liu, Ying ^a   Du, Jiajun ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

E cadherin; Epithelial mesenchymal transition; Immunohistochemistry; Metastasis; Non small cell lung carcinoma; Twist

Indexed keywords

TRANSCRIPTION FACTOR TWIST; UVOMORULIN;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER PATIENT; CLINICAL ARTICLE; COMPARATIVE STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MALE; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SOLID TUMOR; UPREGULATION;

AGED; CADHERINS; CARCINOMA, NON-SMALL-CELL LUNG; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; TWIST TRANSCRIPTION FACTOR;

EID: 79955613190     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2011.01.023     Document Type: Article

References (25)

1. Stinchcombe T.E., Lee C.B., Socinski M.A. Current approaches to advanced-stage non-small-cell lung cancer: first-line therapy in patients with a good functional status. Clin Lung Cancer 2006, 7(Suppl. 4):S111-S117.
2. Thiery J.P. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002, 2:442-454.
3. Huber M.A., Kraut N., Beug H. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 2005, 17:548-558.
4. Castanon I., Baylies M.K. A Twist in fate: evolutionary comparison of Twist structure and function. Gene 2002, 287:11-22.
5. Yang J., Mani S.A., Donaher J.L., Ramaswamy S., Itzykson R.A., Come C., Savagner P., Gitelman I., Richardson A., Weinberg R.A. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004, 117:927-939.
6. Kyo S., Sakaguchi J., Ohno S., Mizumoto Y., Maida Y., Hashimoto M., Nakamura M., Takakura M., Nakajima M., Masutomi K., Inoue M. High Twist expression is involved in infiltrative endometrial cancer and affects patient survival. Hum Pathol 2006, 37:431-439.
7. Kwok W.K., Ling M.T., Lee T.W., Lau T., Zhou C., Zhang X., Chua C.W., Chan K.W., Chan F.L., Glackin C., Wong Y.C., Wang X. Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target. Cancer Res 2005, 65:5153-5162.
8. Zhang Z., Xie D., Li X., Wong Y.C., Xin D., Guan X.Y., Chua C.W., Leung S.C.L., Na Y., Wang X. Significance of TWIST expression and its association with E-cadherin in bladder cancer. Hum Pathol 2007, 38:598-606.
9. Hoek K., Rimm D.L., Williams K.R., Zhao H., Ariyan S., Lin A., Kluger H.M., Berger A.J., Cheng E., Trombetta E.S., Wu T., Niinobe M., Yoshikawa K., Hannigan G.E., Halaban R. Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas. Cancer Res 2004, 64:5270-5282.
10. Elias M.C., Tozer K.R., Silber J.R., Mikheeva S., Deng M., Morrison R.S., Manning T.C., Silbergeld D.L., Glackin C.A., Reh T.A., Rostomily R.C. TWIST is expressed in human gliomas and promotes invasion. Neoplasia 2005, 7:824-837.
11. Entz-Werle N., Stoetzel C., Berard-Marec P., Kalifa C., Brugiere L., Pacquement H., Schmitt C., Tabone M.D., Gentet J.C., Quillet R., Oudet P., Lutz P., Babin-Boilletot A., Gaub M.P., Perrin-Schmitt F. Frequent genomic abnormalities at TWIST in human pediatric osteosarcomas. Int J Cancer 2005, 117:349-355.
12. Mironchik Y., Winnard P.T., Vesuna F., Kato Y., Wildes F., Pathak A.P., Kominsky S., Artemov D., Bhujwalla Z., Diest P.V., Burger H., Glackin C., Raman V. Twist overexpression induces in vivo angiogenesis and correlates with chromosomal instability in breast cancer. Cancer Res 2005, 65:10801-10809.
13. Onder T.T., Gupta P.B., Mani S.A., Yang J., Lander E.S., Weinberg R.A. Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res 2008, 68:3645-3654.
14. Bremnes R.M., Veve R., Gabrielson E., Hirsch F.R., Baron A., Bemis L., Gemmill R.M., Drabkin H.A., Franklin W.A. High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer. J Clin Oncol 2002, 20:2417-2428.
15. Voulgari A., Pintzas A. Epithelial-mesenchymal transition in cancer metastasis: mechanisms, markers and strategies to overcome drug resistance in the clinic. Biochim Biophys Acta 2009, 1796:75-90.
16. Park D., Karesen R., Axcrona U., Noren T., Sauer T. Expression pattern of adhesion molecules (E-cadherin, alpha-, beta-, gamma-catenin and claudin-7), their influence on survival in primary breast carcinoma, and their corresponding axillary lymph node metastasis. Apmis 2007, 115:52-65.
17. Mareel M.M., Behrens J., Birchmeier W., De Bruyne G.K., Vleminckx K., Hoogewijs A., Fiers W.C., Van Roy F.M. Down-regulation of E-cadherin expression in Madin Darby canine kidney (MDCK) cells inside tumors of nude mice. Int J Cancer 1991, 47:922-928.
18. Tortola S., Steinert R., Hantschick M., Peinado M.A., Gastinger I., Stosiek P., Lippert H., Schlegel W., Reymond M.A. Discordance between K-ras mutations in bone marrow micrometastases and the primary tumor in colorectal cancer. J Clin Oncol 2001, 19:2837-2843.
19. Dacic S., Ionescu D.N., Finkelstein S., Yousem S.A. Patterns of allelic loss of synchronous adenocarcinomas of the lung. Am J Surg Pathol 2005, 29:897-902.
20. Petersen I., Petersen S. Towards a genetic-based classification of human lung cancer. Anal Cell Pathol 2001, 22:111-121.
21. Goeze A., Schluns K., Wolf G., Thasler Z., Petersen S., Petersen I. Chromosomal imbalances of primary and metastatic lung adenocarcinomas. J Pathol 2002, 196:8-16.
22. Gallegos Ruiz M.I., van Cruijsen H., Smit E.F., Katrien G., Gerrit A.M., Jose A.R., Ylstra B., Giaccone G. Genetic heterogeneity in patients with multiple neoplastic lung lesions: a report of three cases. J Thorac Oncol 2007, 2:12-21.
23. Grandis J.R., Sok J.C. Signaling through the epidermal growth factor receptor during the development of malignancy. Pharmacol Ther 2004, 102:37-46.
24. Shepherd F.A., Rodrigues Pereira J., Ciuleanu T., Tan E.H., Hirsh V., Thongprasert S., Campos D., Maoleekoonpiroj S., Smylie M., Martins R., van Kooten M., Dediu M., Findlay B., Tu D., Johnston D., Bezjak A., Clark G., Santabarbara P., Seymour L. Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med 2005, 353:123-132.
25. Buck E., Eyzaguirre A., Barr S., Thompson S., Sennello R., Young D., Iwata K.K., Gibson N.W., Cagnoni P., Haley J.D. Loss of homotypic cell adhesion by epithelial-mesenchymal transition or mutation limits sensitivity to epidermal growth factor receptor inhibition. Mol Cancer Ther 2007, 6:532-541.